Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3Other 1

Conditions

Prostatic Neoplasms 63Cardiovascular Diseases 3Neoplasms 2Stage II Prostate Adenocarcinoma 1Sarcopenia 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Osteoporosis 1Oligometastatic Prostate Carcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Metabolic Syndrome 1Metabolic Diseases 1Eunuchism 1Diabetes Mellitus 1Dementia 1Cognitive Dysfunction 1Advanced Prostate Cancer 1

Interventions

Gonadotropin-Releasing Hormone 3acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Nutrition Assessment 2palbociclib 1beta Carotene 1Vitamin E 1Testosterone 1Standard of Care 1Social Determinants of Health 1Simvastatin 1Rosuvastatin Calcium 1Rivaroxaban 1Resistance Training 1Pravastatin 1Practice Guidelines as Topic 1Nutritional Status 1Lysine Acetyltransferase 5 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Health Information Exchange 1Geritol 1Exercise 1Atorvastatin 1Ascorbic Acid 1Angiotensin-Converting Enzyme Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Gonadotropin-Releasing Hormone × Genitourinary × Clear all
NCT05773183 2023-03-17

MMetdMH

Royal College of Surgeons, Ireland

Unknown
60 enrolled
GenitourinaryOther

Cardiovascular Diseases, Diabetes Mellitus, Eunuchism, Metabolic Diseases, Obesity, Prostatic Neoplasms, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease

NCT04182594 2019-12-02

Cardiovascular Events in GnRH Agonist vs. Antagonist

Rabin Medical Center

Phase 2 Unknown
80 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

NCT02475057 2019-06-12

Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists

Rabin Medical Center

Phase 4 Completed
80 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡